头颈部CTA尖段肺评估作为急性卒中COVID-19筛查工具的价值
本研究分析57例急性缺血性卒中患者头颈部CTA尖段肺评估对COVID-19特异性肺部表现的诊断效用,单独尖段肺评估诊断COVID-19的敏感度0.67、特异度0.93、阳性预测值0.19、阴性预测值0.99、准确率0.92;联合自报咳嗽或气促症状后敏感度提升至0.83,提示尖段肺评估可作为急性卒中联合筛查的一部分。
要点
- 急性缺血性卒中头颈部CTA尖段肺评估诊断COVID-19特异度0.93、阴性预测值0.99。
- 单独尖段肺评估敏感度0.67,联合咳嗽或气促症状后敏感度升至0.83。
- 尖段肺评估可作为急性卒中COVID-19联合筛查策略的组成部分。
核心结论
- 头颈部CTA尖段肺评估是准确的COVID-19筛查工具,可作为急性缺血性卒中联合筛查方法的一部分。
研究设计与样本
- 对57例因急性缺血性卒中就诊的患者进行分析,评估头颈部CTA尖段肺评估对COVID-19特异性肺部表现的诊断效用。
主要发现
- 单独尖段肺评估诊断COVID-19的敏感度0.67、特异度0.93、阳性预测值0.19、阴性预测值0.99、准确率0.92。
- 尖段肺评估联合自报咳嗽或气促症状后,敏感度提升至0.83。
关键数值与推荐
- 单独尖段肺评估:敏感度0.67、特异度0.93、阳性预测值0.19、阴性预测值0.99、准确率0.92。
- 联合自报咳嗽或气促症状:敏感度0.83。
临床怎么用
- 在急性缺血性卒中患者头颈部CTA检查中,可评估尖段肺以辅助COVID-19筛查。
- 建议将尖段肺评估与患者自报咳嗽或气促症状结合用于联合筛查。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Evaluation of the lung apices using computed tomography angiography of the head and neck during acute ischemic stroke (AIS) can provide the first objective opportunity to screen for coronavirus disease 2019 (COVID-19). METHODS: We performed an analysis assessing the utility of apical lung exam on computed tomography angiography for COVID-19-specific lung findings in 57 patients presenting with AIS. We measured the diagnostic accuracy of apical lung assessment alone and in combination with patient-reported symptoms and incorporate both to propose a COVID-19 era AIS algorithm. RESULTS: Apical lung assessment when used in isolation, yielded a sensitivity of 0.67, specificity of 0.93, positive predictive value of 0.19, negative predictive value of 0.99, and accuracy of 0.92 for the diagnosis of COVID-19, in patients presenting to the hospital for AIS. When combined with self-reported clinical symptoms of cough or shortness of breath, sensitivity of apical lung assessment improved to 0.83. CONCLUSIONS: Apical lung assessment on computed tomography angiography is an accurate screening tool for COVID-19 and can serve as part of a combined screening approach in AIS.
引用
- Esenwa C, Lee JA, Nisar T, et al. Utility of Apical Lung Assessment on Computed Tomography Angiography as a COVID-19 Screen in Acute Stroke. Stroke. 2020. PMID: 33115325. doi:10.1161/STROKEAHA.120.030959
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。